These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 28756593)
81. Impact of radiation on immune cells in patients with low-grade brain tumor: Identifying critical factors affecting lymphopenia and neutrophil-to-lymphocyte ratio. Choi YK; Jang HS; Choi BO; Lee SW; Song JH Radiat Oncol J; 2023 Jun; 41(2):120-128. PubMed ID: 37403354 [TBL] [Abstract][Full Text] [Related]
82. Aspergillosis in a patient receiving temozolomide for the treatment of glioblastoma. Munhoz RR; Pereira Picarelli AA; Troques Mitteldorf CA; Feher O Case Rep Oncol; 2013; 6(2):410-5. PubMed ID: 24019780 [TBL] [Abstract][Full Text] [Related]
83. Prognostic Value and Risk Factors of Treatment-Related Lymphopenia in Malignant Glioma Patients Treated With Chemoradiotherapy: A Systematic Review and Meta-Analysis. Zhang Y; Chen S; Chen H; Chen S; Li Z; Feng E; Li W Front Neurol; 2021; 12():726561. PubMed ID: 35058869 [No Abstract] [Full Text] [Related]
84. Non-hodgkin lymphoma after treatment with extended dosing temozolomide and radiotherapy for a glioblastoma: a case report. Van Ginderachter L; Cox T; Drijkoningen R; Achten R; Joosens E; Maes A; Theunissen K; Mebis J Case Rep Oncol; 2013 Jan; 6(1):45-9. PubMed ID: 23466981 [TBL] [Abstract][Full Text] [Related]
85. Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors. Qian JM; Akama-Garren E; Shin J; Gunasti L; Bang A; Pike LRG; Grassberger C; Schoenfeld JD Adv Radiat Oncol; 2022; 7(2):100880. PubMed ID: 35097241 [TBL] [Abstract][Full Text] [Related]
86. Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients. Dutoit V; Philippin G; Widmer V; Marinari E; Vuilleumier A; Migliorini D; Schaller K; Dietrich PY Front Oncol; 2020; 10():89. PubMed ID: 32117743 [TBL] [Abstract][Full Text] [Related]
87. Patient-Specific Lymphocyte Loss Kinetics as Biomarker of Spleen Dose in Patients Undergoing Radiation Therapy for Upper Abdominal Malignancies. Yalamanchali A; Zhang H; Huang KC; Mohan R; Lin SH; Zhu C; Grossman SA; Jin JY; Ellsworth SG Adv Radiat Oncol; 2021; 6(1):100545. PubMed ID: 33665481 [TBL] [Abstract][Full Text] [Related]
88. [Mechanisms of radiation-induced lymphopenia and therapeutic impact]. Cesaire M; Le Mauff B; Rambeau A; Toutirais O; Thariat J Bull Cancer; 2020; 107(7-8):813-822. PubMed ID: 32451070 [TBL] [Abstract][Full Text] [Related]
89. Effect of Cumulative Dexamethasone Dose during Concomitant Chemoradiation on Lymphopenia in Patients with Newly Diagnosed Glioblastoma. Lee C; Ahn S; Park JS; Song JH; Hong YK; Jeun SS Brain Tumor Res Treat; 2020 Oct; 8(2):71-76. PubMed ID: 32648384 [TBL] [Abstract][Full Text] [Related]
90. Microvesicles as a Biomarker for Tumor Progression versus Treatment Effect in Radiation/Temozolomide-Treated Glioblastoma Patients. Koch CJ; Lustig RA; Yang XY; Jenkins WT; Wolf RL; Martinez-Lage M; Desai A; Williams D; Evans SM Transl Oncol; 2014 Dec; 7(6):752-8. PubMed ID: 25500085 [TBL] [Abstract][Full Text] [Related]
91. Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide. Khaddour K; Harrison N; Govindan A; Campian JL Case Rep Oncol; 2020; 13(3):1244-1251. PubMed ID: 33250738 [TBL] [Abstract][Full Text] [Related]
92. PrACTiC: A Predictive Algorithm for Chemoradiotherapy-Induced Cytopenia in Glioblastoma Patients. Amouheidari A; Alirezaei Z; Rauh S; Hassanpour M J Oncol; 2022; 2022():1438190. PubMed ID: 35111223 [TBL] [Abstract][Full Text] [Related]
93. Evaluation of high-grade astrocytoma recurrence patterns after radiotherapy in the era of temozolomide: A single institution experience. Lotar Cordova A; Almeida TVR; Silva CMD; Piedade PA; Almeida CM; Bezzera Lima CG; Dutra C; Ferreira RM; Linhares MN; Denyak V Rep Pract Oncol Radiother; 2018; 23(3):154-160. PubMed ID: 29760590 [TBL] [Abstract][Full Text] [Related]
94. Letter to the editor concerning 'Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies'. Hassan WA; Bjerre M; Hjortebjerg R; Magnusson NE; Ramshanker N; Frystyk J Ann Oncol; 2015 Jan; 26(1):252-253. PubMed ID: 25355718 [No Abstract] [Full Text] [Related]
95. The effect of pelvic radiation alone on lymphocyte subgroups. Swanson GP; Jhavar SG; Hammonds K Clin Transl Radiat Oncol; 2020 Jul; 23():100-102. PubMed ID: 32548314 [TBL] [Abstract][Full Text] [Related]
96. In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment. Chitadze G; Flüh C; Quabius ES; Freitag-Wolf S; Peters C; Lettau M; Bhat J; Wesch D; Oberg HH; Luecke S; Janssen O; Synowitz M; Held-Feindt J; Kabelitz D Oncoimmunology; 2017; 6(11):e1358839. PubMed ID: 29147621 [TBL] [Abstract][Full Text] [Related]